Report #2831779

Received Mar 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: Feb 17, 2025
Onset: Feb 24, 2025
Days to onset: 7
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Rash

Symptom narrative

Rash everywhere; This non-serious case was reported by a consumer and described the occurrence of generalized rash in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included transcatheter aortic valve replacement. Concomitant products included apixaban (Eliquis). On 17-FEB-2025, the patient received Shingrix. On 24-FEB-2025, 7 days after receiving Shingrix, the patient experienced generalized rash (Verbatim: Rash everywhere). The outcome of the generalized rash was not resolved. It was unknown if the reporter considered the generalized rash to be related to Shingrix. It was unknown if the company considered the generalized rash to be related to Shingrix. Additional Information: GSK Receipt Date: 11-MAR-2025 The case was self reported by patient. The patient received Shingrix vaccine and experienced rash everywhere.

Medical history

Medical History/Concurrent Conditions: Transcatheter aortic valve replacement

Other medications

ELIQUIS